Skip to main content
. 2017 Aug 2;2017(8):CD001324. doi: 10.1002/14651858.CD001324.pub5
Methods Women randomly allocated to 2 groups. Method of randomisation not reported
Participants Prospective, randomised, comparative study, including 124 healthy volunteers who, in the observed cycle, had had only 1 act of unprotected intercourse within 72 h of treatment
Randomly allocated to LNG (n = 62) and Yuzpe (n = 62)
Interventions Yuzpe: involved 2 doses of combined oestrogen/progestin pills, with each dose containing 100 μg of ethinyl oestradiol and 500 μg of LNG
LNG: LNG 0.75 mg taken within 72 h of unprotected coitus and LNG 0.75 mg taken 12 h later
Outcomes Observed number of pregnancies, side effects and changes in menstrual pattern
Notes
  1. Observed pregnancy/total number of women: Yuzpe: 5/60 (2 lost to follow‐up); LNG: 0/62

  2. Side effects:

    1. Nausea: Yuzpe 41/60; LNG 4/62

    2. Vomiting: Yuzpe 15/60; LNG 0/62

    3. Headache: Yuzpe 13/60; LNG 0/62

    4. Weakness: Yuzpe 10/60; LNG 1/62

    5. Hot flushes: Yuzpe 4/60; LNG 2/62

Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk "Randomisation was done by randomisation schedules"‐ doesn't clarify what kind of schedule or how it was generated
Allocation concealment (selection bias) Unclear risk Does not state if there was any allocation concealment
Blinding (performance bias and detection bias) All outcomes Unclear risk Does not state if blinding was present
Incomplete outcome data (attrition bias) All outcomes Low risk "Two women were excluded from the study because they were lost to follow‐up" Explains the lost participants as loss to follow‐up. Analysed all others
Selective reporting (reporting bias) Unclear risk The primary and secondary planned outcomes are not clearly stated in the methods and there is no protocol available to check.
Other bias Low risk None detected